The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
Bradford Crutchfield, insider at 10x Genomics

Bradford Crutchfield Insider Information

Insider of 10x Genomics
Brad Crutchfield has served as the Chief Commercial Officer of 10x Genomics since 2017, bringing more than 30 years of experience in commercial sales and marketing leadership to the company. Prior to joining 10x Genomics, he was QIAGEN’s Senior Vice President, life sciences business area, expanding the company’s global presence in the academic, pharmaceutical, and applied testing industries. Brad also served as Vice President and General Manager, Europe, Middle East & Africa for Illumina, and held positions of increasing responsibility with Bio-Rad Laboratories rising to Executive Vice President and President of the Life Science Group. He has also served as a director for Nanostring Technologies. Brad earned a B.S. in Physiology from the University of California, Davis.

What is Bradford Crutchfield's net worth?

The estimated net worth of Bradford Crutchfield is at least $2.83 million as of September 13th, 2021. Mr. Crutchfield owns 60,336 shares of 10x Genomics stock worth more than $2,832,172 as of August 10th. This net worth evaluation does not reflect any other assets that Mr. Crutchfield may own. Additionally, Mr. Crutchfield receives an annual salary of $503,370.00 as Insider at 10x Genomics. Learn More about Bradford Crutchfield's net worth.

How old is Bradford Crutchfield?

Mr. Crutchfield is currently 59 years old. There are 4 older executives and no younger executives at 10x Genomics. Learn More on Bradford Crutchfield's age.

What is Bradford Crutchfield's salary?

As the Insider of 10x Genomics, Inc., Mr. Crutchfield earns $503,370.00 per year. There are 2 executives that earn more than Mr. Crutchfield. The highest earning executive at 10x Genomics is Dr. Serge Saxonov Ph.D., Co-Founder, CEO & Director, who commands a salary of $736,520.00 per year. Learn More on Bradford Crutchfield's salary.

How do I contact Bradford Crutchfield?

The corporate mailing address for Mr. Crutchfield and other 10x Genomics executives is 6230 STONERIDGE MALL ROAD, PLEASANTON CA, 94588. 10x Genomics can also be reached via phone at 925-401-7300 and via email at [email protected] Learn More on Bradford Crutchfield's contact information.

Has Bradford Crutchfield been buying or selling shares of 10x Genomics?

Bradford Crutchfield has not been actively trading shares of 10x Genomics during the past quarter. Most recently, Bradford Crutchfield sold 17,000 shares of the business's stock in a transaction on Tuesday, February 15th. The shares were sold at an average price of $95.13, for a transaction totalling $1,617,210.00. Learn More on Bradford Crutchfield's trading history.

Who are 10x Genomics' active insiders?

10x Genomics' insider roster includes Bradford Crutchfield (Insider), Benjamin Hindson (Insider), Sridhar Kosaraju (Director), Justin McAnear (CFO), Serge Saxonov (CEO), and John Stuelpnagel (Director). Learn More on 10x Genomics' active insiders.

Are insiders buying or selling shares of 10x Genomics?

During the last year, 10x Genomics insiders bought shares 1 times. They purchased a total of 158 shares worth more than $6,397.42. During the last year, insiders at the sold shares 45 times. They sold a total of 497,169 shares worth more than $74,775,539.89. The most recent insider tranaction occured on May, 23rd when CEO Serge Saxonov sold 2,656 shares worth more than $129,506.56. Insiders at 10x Genomics own 11.1 % of the company. Learn More about insider trades at 10x Genomics.

Information on this page was last updated on 5/23/2022.

Bradford Crutchfield Insider Trading History at 10x Genomics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/15/2022Sell17,000$95.13$1,617,210.00View SEC Filing Icon  
1/12/2022Sell17,000$119.00$2,023,000.00View SEC Filing Icon  
12/13/2021Sell17,000$139.36$2,369,120.00View SEC Filing Icon  
11/12/2021Sell17,000$164.92$2,803,640.00View SEC Filing Icon  
10/12/2021Sell17,000$157.30$2,674,100.00View SEC Filing Icon  
9/13/2021Sell17,000$174.49$2,966,330.0060,336View SEC Filing Icon  
7/12/2021Sell17,000$186.53$3,171,010.00View SEC Filing Icon  
6/14/2021Sell17,000$191.69$3,258,730.0060,262View SEC Filing Icon  
5/12/2021Sell17,000$134.78$2,291,260.0051,608View SEC Filing Icon  
4/12/2021Sell17,000$185.89$3,160,130.0051,608View SEC Filing Icon  
See Full Table

Bradford Crutchfield Buying and Selling Activity at 10x Genomics

This chart shows Bradford Crutchfield's buying and selling at 10x Genomics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

10x Genomics Company Overview

10x Genomics logo
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Read More

Today's Range

Now: $46.94
Low: $44.80
High: $47.35

50 Day Range

MA: $42.76
Low: $34.65
High: $52.59

2 Week Range

Now: $46.94
Low: $33.30
High: $191.15

Volume

1,218,577 shs

Average Volume

1,474,789 shs

Market Capitalization

$5.30 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.66
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!